Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Earnings save search
Avinger to Announce Full-Year 2021 Results on March 22
Published: 2022-03-15 (Crawled : 12:30) - biospace.com/
AVGR | $4.02 2.55% 2.49% 5.6K
|
Health Technology
|
| O: 1724.4%
H: 0.0%
C: 0.0%
results
NeuroMetrix Reports Q2 2021 Financial Results
Published: 2021-07-22 (Crawled : 12:00) - biospace.com/
NURO | News | $4.28 17.26% 14.72% 250K
|
Health Technology
|
| O: 85.48%
H: 0.44%
C: -35.9%
financial results results
Addex Provides Corporate Update and Financial Guidance
Published: 2022-07-21 (Crawled : 11:00) - biospace.com/
ADXN | News | $19.0 -9.35% -10.32% 20K
|
Health Technology
|
| O: 72.24%
H: 57.59%
C: 22.15%
update
Fulcrum Therapeutics Reports Recent Business Highlights and Second Quarter 2021 Financial Results
Published: 2021-08-10 (Crawled : 13:00) - biospace.com/
FULC | $6.86 -2.83% -2.92% 560K
|
Health Technology
|
| O: 58.58%
H: 67.22%
C: 42.09%
financial results results
Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2023
Published: 2023-04-25 (Crawled : 12:20) - biospace.com/
MORF | $28.0 1.78% 1.75% 380K
|
Health Technology
|
| O: 26.01%
H: 0.22%
C: -14.86%
financial results
Chemomab Therapeutics Announces Fourth Quarter and Year End 2021 Financial Results and Provides a Corporate Update
Published: 2022-03-09 (Crawled : 12:00) - biospace.com/
CMMB | $0.691 -1.29% -1.3% 15K
|
Manufacturing
|
| O: 25.45%
H: 0.0%
C: -8.45%
financial results therapeutics results
EyePoint Pharmaceuticals Investor Day to Highlight EYP-1901 and Durasert® Technology Developments and Provide a Financial Update
Published: 2022-07-18 (Crawled : 12:20) - biospace.com/
EYPT | $17.665 0.94% 0.93% 1.5M
|
Health Technology
|
| O: 23.94%
H: 2.62%
C: -1.51%
eyp-1901 durasert day technology update
Veru Reports Third Quarter Fiscal 2022 Financial Results; Progresses Sabizabulin Treatment for COVID-19 Towards Regulatory Decisions in Key Territories
Published: 2022-08-11 (Crawled : 12:00) - biospace.com/
VERU | $1.305 -8.1% -8.81% 2.6M
|
Health Technology
|
| O: 20.82%
H: 26.51%
C: 12.59%
covid-19 treatment sabizabulin
Neuronetics to Report Second Quarter 2022 Financial and Operating Results and Host Conference Call
Published: 2022-07-19 (Crawled : 13:20) - biospace.com/
STIM | $3.8 -0.78% -0.79% 49K
|
Health Technology
|
| O: 20.6%
H: 3.87%
C: -13.21%
conference report results
Salarius Pharmaceuticals Reports Business Highlights with Fourth Quarter and Full-Year 2021 Financial Results
Published: 2022-03-10 (Crawled : 22:00) - biospace.com/
SLRX | $0.4848 -2.88% 6.2K
|
Commercial Services
|
| O: 17.42%
H: 0.0%
C: 0.0%
als financial results report results
BrainStorm Cell Therapeutics Announces Second Quarter 2022 Financial Results and Provides a Corporate Update
Published: 2022-08-15 (Crawled : 12:00) - biospace.com/
BCLI A | $0.5384 4.69% 4.48% 1M
|
Health Technology
|
| O: 17.14%
H: 14.63%
C: -15.85%
therapeutics update results
LifeStance Reports Fourth Quarter and Full Year 2022 Results
Published: 2023-03-08 (Crawled : 22:00) - biospace.com/
LFST S | $5.7 -0.18% -0.18% 860K
|
Manufacturing
|
| O: 17.09%
H: 13.69%
C: 0.9%
year results
AdaptHealth Corp. Announces Fourth Quarter and Full-Year 2023 Results and Provides Initial 2024 Outlook
Published: 2024-02-27 (Crawled : 13:30) - biospace.com/
AHCO | $9.34 -0.21% -0.21% 1.1M
|
Finance
|
| O: 16.78%
H: 14.09%
C: 12.23%
results
Avinger Expands Intellectual Property Portfolio
Published: 2021-01-19 (Crawled : 17:00) - biospace.com/
AVGR | $4.02 2.55% 2.49% 5.6K
|
Health Technology
|
| O: 15.31%
H: 26.25%
C: 15.63%
expansion
Revance Provides an Update on DAXXIFY® Commercial Launch and Preliminary Fourth Quarter and Full Year 2022 Financial Results
Published: 2023-01-09 (Crawled : 19:00) - biospace.com/
VTRS A | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: 0.17%
H: 0.58%
C: -0.91%
RVNC | $3.77 -0.53% -0.53% 1.6M
|
Health Technology
|
| O: 15.12%
H: 34.86%
C: 34.07%
daxxify commercial year financial update results
Syros to Report Fourth Quarter and Full Year 2021 Financial Results on Tuesday, March 15, 2022
Published: 2022-03-09 (Crawled : 13:00) - biospace.com/
SYRS | $4.54 -3.81% -3.96% 260K
|
Health Technology
|
| O: 15.12%
H: 7.63%
C: 7.63%
day financial results report results
Spectrum Pharmaceuticals Provides Update on ROLVEDON™ (eflapegrastim-xnst) Injection and Announces Unaudited Fourth Quarter 2022 Financial Results
Published: 2023-01-31 (Crawled : 13:00) - biospace.com/
SPPI | $1.03 -0.97% 0
|
Health Technology
|
| O: 14.56%
H: 16.08%
C: 12.9%
pharmaceuticals financial injection update results
With Sales Up Over 120%, Pressure BioSciences to Host Q1 2021 Financial Results and Business Update on Wednesday, May 19, 2021
Published: 2021-05-18 (Crawled : 18:00) - biospace.com/
PBIO | $0.2697 88.01% 37K
|
Health Technology
|
| O: 14.37%
H: 4.02%
C: -12.56%
sales financial results results
RenovoRx Reports Second Quarter 2023 Financial Results and Operational Highlights
Published: 2023-08-17 (Crawled : 18:00) - biospace.com/
RNXT | $1.23 0.82% 0.81% 20K
|
|
| O: 14.04%
H: 0.0%
C: -5.64%
financial results
IPA Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2024
Published: 2023-09-14 (Crawled : 14:00) - biospace.com/
IPA | $1.24 0.0% 150K
|
Professional, Scientific, and T...
|
| O: 13.86%
H: 0.0%
C: -13.04%
business year financial results
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.